Literature DB >> 15068125

Pathophysiology of type 2 diabetes.

A J Scheen1.   

Abstract

Type 2 diabetes mellitus is a heterogeneous syndrome characterized by abnormalities in carbohydrate and fat metabolism. The causes of type 2 diabetes are multi-factorial and include both genetic and environmental elements that affect beta-cell function and tissue (muscle, liver, adipose tissue, pancreas) insulin sensitivity. Although there is considerable debate as to the relative contributions of beta-cell dysfunction and reduced insulin sensitivity to the pathogenesis of diabetes, it is generally agreed that both these factors play important roles. However, the mechanisms controlling the interplay of these two impairments are unclear. A number of factors have been suggested as possibly linking insulin resistance and beta-cell dysfunction in the pathogenesis of type 2 diabetes. A majority of individuals suffering from type 2 diabetes are obese, with central visceral adiposity. Therefore, the adipose tissue should play a crucial role in the pathogenesis of type 2 diabetes. Although the predominant paradigm used to explain this link is the portal/visceral hypothesis giving a key role in elevated non-esterified fatty acid concentrations, two new emerging paradigms are the ectopic fat storage syndrome (deposition of triglycerides in muscle, liver and pancreatic cells) and the adipose tissue as endocrine organ hypothesis (secretion of various adipocytokins, i.e. leptin, TNF-alpha, resistin, adiponectin, implicated in insulin resistance and possibly beta-cell dysfunction). These two paradigms constitute the framework for the study of the interplay between insulin resistance and beta-cell dysfunction in type 2 diabetes as well as between our obesogenic environment and diabetes risk in the next decade.

Entities:  

Mesh:

Year:  2003        PMID: 15068125     DOI: 10.1179/acb.2003.58.6.001

Source DB:  PubMed          Journal:  Acta Clin Belg        ISSN: 1784-3286            Impact factor:   1.264


  50 in total

1.  Computational pharmacokinetics and in vitro-in vivo correlation of anti-diabetic synergistic phyto-composite blend.

Authors:  Baishakhi De; Koushik Bhandari; Nishant Chakravorty; Ranjan Mukherjee; Rohit Gundamaraju; Rajeev K Singla; Prakash Katakam; Shanta K Adiki; Biswajoy Ghosh; Analava Mitra
Journal:  World J Diabetes       Date:  2015-09-10

Review 2.  Pharmacokinetic interactions with thiazolidinediones.

Authors:  André J Scheen
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

3.  The clinical biochemistry of obesity.

Authors:  Ken A Sikaris
Journal:  Clin Biochem Rev       Date:  2004-08

4.  A low GLP-1 response among patients treated for acute organophosphate and carbamate poisoning: a comparative cross-sectional study from an agrarian region of Sri Lanka.

Authors:  Devarajan Rathish; Indika Senavirathna; Channa Jayasumana; Suneth Agampodi; Sisira Siribaddana
Journal:  Environ Sci Pollut Res Int       Date:  2018-11-29       Impact factor: 4.223

5.  Intrauterine Hyperglycemia Is Associated with an Impaired Postnatal Response to Oxidative Damage.

Authors:  Jessica N Tozour; Fabien Delahaye; Masako Suzuki; Aaron Praiss; Yongmei Zhao; Lingguang Cai; Hye J Heo; John M Greally; Francine Hughes
Journal:  Stem Cells Dev       Date:  2018-04-26       Impact factor: 3.272

Review 6.  The Physiological Effects of Dandelion (Taraxacum Officinale) in Type 2 Diabetes.

Authors:  Fonyuy E Wirngo; Max N Lambert; Per B Jeppesen
Journal:  Rev Diabet Stud       Date:  2016-08-10

7.  PPAR{alpha} mediates the hypolipidemic action of fibrates by antagonizing FoxO1.

Authors:  Shen Qu; Dongming Su; Jennifer Altomonte; Adama Kamagate; Jing He; German Perdomo; Tonia Tse; Yu Jiang; H Henry Dong
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-09-19       Impact factor: 4.310

8.  Effect of Curcumin on Glycemic Control in Patients with Type 2 Diabetes: A Systematic Review of Randomized Clinical Trials.

Authors:  Atena Mahdavi; Sajjad Moradi; Gholamreza Askari; Bijan Iraj; Thozhukat Sathyapalan; Paul C Guest; Mohammad Bagherniya; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  Oral delivery of bioencapsulated exendin-4 expressed in chloroplasts lowers blood glucose level in mice and stimulates insulin secretion in beta-TC6 cells.

Authors:  Kwang-Chul Kwon; Ramya Nityanandam; James S New; Henry Daniell
Journal:  Plant Biotechnol J       Date:  2012-10-18       Impact factor: 9.803

10.  Flavonoid-rich extract of Chromolaena odorata modulate circulating GLP-1 in Wistar rats: computational evaluation of TGR5 involvement.

Authors:  Olaposi Idowu Omotuyi; Oyekanmi Nash; Olumide Kayode Inyang; Joyce Ogidigo; Ojochenemi Enejoh; Okiemute Okpalefe; Tsuyoshi Hamada
Journal:  3 Biotech       Date:  2018-02-13       Impact factor: 2.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.